← Open Payments lookup

MELISSA DEER: Open Payments

NPI 1043415888 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,643 in 76 payments from 10 companies in 2025. Trend: 2023 $75 · 2024 $259 · 2025 $1,643

Food & beverage: $1,638Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$336
Tris Pharma Inc3$214
Alkermes, Inc.15$211
Vanda Pharmaceuticals Inc.8$206
Otsuka America Pharmaceutical, Inc.9$161
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$147
E.R. Squibb & Sons, L.L.C.5$108
Janssen Pharmaceuticals, Inc6$107
Teva Pharmaceuticals USA, Inc.5$95
ABBVIE INC.3$57

Products named: INGREZZA, FANAPT, Dyanavel XR, ARISTADA, CAPLYTA, COBENFY, INVEGA SUSTENNA, REXULTI.

Industry payments across CA — which companies pay providers there.